论文部分内容阅读
目的:探讨经利多卡因医治急性发作的慢性喘息型支气管炎患者的疗效。方法:随机将130例患支气管炎者(慢性喘息型)分组:甲发作组(65例)与乙发作组(65例),对甲发作组经支气管炎常规诊治,对乙发作组经常规+利多卡因诊治。给予7d的诊治后,对甲发作组与乙发作组的疗效进行分析与比较。结果:乙发作组的疗效比甲发作组好,P<0.05。乙发作组的心率情况、呼吸频率状况改善比甲发作组明显,P<0.05。乙发作组的动脉血压值比甲发作组高,P<0.05,乙发作组的二氧化碳分压数值比甲发作组低,P<0.05。结论:经利多卡因医治急性发作的慢性喘息型支气管炎患者的疗效很明显,能有效改善患者的心率、呼吸频率,加速恢复。
Objective: To investigate the curative effect of chronic asthmatic bronchitis treated with lidocaine for acute attack. Methods: One hundred and thirteen patients with bronchitis (chronic asthmatic type) were randomly divided into two groups: A group (65 cases) and B group (65 cases). A group was treated by bronchitis routinely. Lidocaine diagnosis and treatment. After given 7d diagnosis and treatment, the efficacy of A group and B group were analyzed and compared. Results: The efficacy of group B was better than that of group A, P <0.05. In the B-episode group, heart rate and respiratory rate improved significantly compared with those in the A-episode (P <0.05). The arterial blood pressure in group B was higher than that in group A (P <0.05). The partial pressure of carbon dioxide in group B was lower than that in group A (P <0.05). Conclusion: The efficacy of lidocaine in treating acute asthmatic bronchitis patients is very obvious. It can effectively improve the heart rate and respiratory rate of patients and accelerate the recovery.